|
2019 Book Chapter Cast nephropathyHutchison, Colin A. and Mollee, Peter (2019). Cast nephropathy. Onco-nephrology. (pp. 59-66.e3) edited by Kevin W. Finkel, Mark A. Perazella and Eric P. Cohen. Amsterdam, Netherlands: Elsevier. doi: 10.1016/B978-0-323-54945-5.00016-3 |
|
2019 Journal Article PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemiaEnya Chen, Yu-Chen, Burgess, Melinda, Mapp, Sally, Mollee, Peter, Gill, Devinder, Blumenthal, Antje and Saunders, Nicholas A. (2019). PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia. Leukemia, 34 (2), 451-461. doi: 10.1038/s41375-019-0556-z |
|
2018 Journal Article A Comparison of High-Dose Cytarabine during Induction Versus Consolidation Therapy in Newly Diagnosed AMLSchwarer, Anthony P., Butler, Jason, Jackson, Kathryn, Beligaswatte, Ashanka, Martin, Louisa, Kennedy, Glen, Daniela, Zantomio, Lewis, Ian, Hiwase, Devendra, Wight, Joel, He, Simon, Grigg, Andrew, Morris, Kirk, Mollee, Peter and Marlton, Paula (2018). A Comparison of High-Dose Cytarabine during Induction Versus Consolidation Therapy in Newly Diagnosed AML. HemaSphere, 2 (6) e158, 1-8. doi: 10.1097/HS9.0000000000000158 |
|
2018 Journal Article Response to Letter to the Editor about immunochemical measurement of urine free light chainsTate, Jillian R. and Mollee, Peter (2018). Response to Letter to the Editor about immunochemical measurement of urine free light chains. Clinical Chemistry and Laboratory Medicine, 57 (2), e3-e4. doi: 10.1515/cclm-2018-1082 |
|
2018 Journal Article Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: a retrospective analysis based on the prospective, international, multicenter PTLD-1 trialsZimmermann, Heiner, Babel, Nina, Dierickx, Daan, Morschhauser, Franck, Mollee, Peter, Zaucha, Jan M., Dreyling, Martin H., Dührsen, Ulrich, Reinke, Petra, Verhoef, Gregor, Subklewe, Marion, Hüttmann, Andreas, Tousseyn, Thomas, Bachy, Emmanuel, Hauser, Ingeborg A., Tarella, Corrado, Van Den Neste, Eric, Gheysens, Olivier, Anagnostopoulos, Ioannis, Leblond, Veronique, Riess, Hanno, Choquet, Sylvain and Trappe, Ralf U. (2018). Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: a retrospective analysis based on the prospective, international, multicenter PTLD-1 trials. Transplantation, 102 (11), 1914-1923. doi: 10.1097/TP.0000000000002269 |
|
2018 Journal Article Pomalidomide – author replyScott, Ashleigh P. and Mollee, Peter (2018). Pomalidomide – author reply. Leukemia and Lymphoma, 60 (4), 1-1. doi: 10.1080/10428194.2018.1516884 |
|
2018 Journal Article Relative survival of patients with lymphoma in Queensland according to histological subtypeWright, Fraser, Hapgood, Greg, Loganathan, Aravi, Dunn, Nathan, Philpot, Shoni, Moore, Julie and Mollee, Peter (2018). Relative survival of patients with lymphoma in Queensland according to histological subtype. Medical Journal of Australia, 209 (4), 166-172. doi: 10.5694/mja17.00937 |
|
2018 Journal Article Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myelomaQuach, Hang, Benson, Simon, Haysom, Helen, Wilkes, Anne-Marie, Zacher, Nicole, Cole-Sinclair, Merrole, Miles Prince, Henry, Mollee, Peter, Spencer, Andrew, Joy Ho, Phoebe, Harrison, Simon J, Lee, Cindy, Augustson, Bradley and Daly, James (2018). Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma. Internal Medicine Journal, 48 (2), 210-220. doi: 10.1111/imj.13707 |
|
2018 Conference Publication The Tumour Microenvironment as an Independent Prognostic Biomarker in Follicular LymphomaTobin, J., Keane, C., Mollee, P., Birch, S., Gould, C., Gunawardana, J., Hoang, T., Savarimuthu, S., Ma, T., Li, L., Murigneux, V. , Fink, L., Matigian, N. and Gandhi, M. K. (2018). The Tumour Microenvironment as an Independent Prognostic Biomarker in Follicular Lymphoma. RACP Congress 2018, Disruption for Healthy Futures, Sydney, NSW Australia, 14–16 May 2018. Hoboken, NJ United States: Wiley. doi: 10.1111/imj.2_13826 |
|
2018 Conference Publication Activation of Fc Gamma Receptor-Dependent Responses to Therapeutic Antibodies By Nurse like Cells Requires PI3KdeltaChen, Yu-Chen Enya, Burgess, Melinda Lea, Blumenthal, Antje, Mapp, Sally, Mollee, Peter, Gill, Devinder and Saunders, Nicholas Andrew (2018). Activation of Fc Gamma Receptor-Dependent Responses to Therapeutic Antibodies By Nurse like Cells Requires PI3Kdelta. 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA United States, 1-4 December 2018. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2018-99-109719 |
|
2018 Conference Publication Perspectives on physical activity of clinical haematologists and their patients with multiple myelomaNicol, Jennifer L., Burton, Nicola W., Woodrow, Carmel, Mollee, Peter, Hill, Michelle M., Nicol, Andrew J. and Skinner, Tina L. (2018). Perspectives on physical activity of clinical haematologists and their patients with multiple myeloma. COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, Perth, Western Australia, 13–15 November 2018. Hoboken, NJ United States: Wiley. |
|
2017 Conference Publication The tumor microenvironment is independently prognostic of conventional and clinicogenetic risk models in follicular lymphomaTobin, Joshua W. D., Keane, Colm, Mollee, Peter, Birch, Simone, Gould, Clare, Gunawardana, Jay, Hoang, Thanh, Ma, Ti, Abro, Emad Uddin, Shanavas, Mohamed, Yoo, Hyung, Li, Li, Scuffham, Paul, Murigneux, Valentine, Fink, Lynn, Matigian, Nicholas, Vari, Frank, Francis, Santiyagu and Gandhi, Maher K. (2017). The tumor microenvironment is independently prognostic of conventional and clinicogenetic risk models in follicular lymphoma. 59th Annual Meeting of the American-Society-of-Hematology (ASH), Atlanta, GA United States, 9-12 December 2017. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.V130.Suppl_1.728.728 |
|
2017 Journal Article A global call to arms for clinical laboratories - Harmonised quantification and reporting of monoclonal proteinsTate, Jillian R., Keren, David F. and Mollee, Peter (2017). A global call to arms for clinical laboratories - Harmonised quantification and reporting of monoclonal proteins. Clinical Biochemistry, 51, 4-9. doi: 10.1016/j.clinbiochem.2017.11.009 |
|
2017 Journal Article The treatment of paraprotein-related kidney diseaseHutchison, Colin A., Xiong, Fei and Mollee, Peter (2017). The treatment of paraprotein-related kidney disease. Current Opinion in Nephrology and Hypertension, 26 (6), 477-483. doi: 10.1097/MNH.0000000000000369 |
|
2017 Journal Article ‘Real-world’ Australian experience of pomalidomide for relapsed and refractory myelomaScott, Ashleigh, Weber, Nicholas, Tiley, Campbell, Taylor, Kerry, Taper, John, Harrison, Simon, Chan, Kah-Lok, Stark, Richard, Lee, Cindy, Morris, Kirk, Ho, P. Joy, Dodds, Anthony, Ramanathan, Sundra, Ramakrishna, Raj, Watson, Anne-Marie, Auguston, Bradley, Kwok, Fiona, Quach, Hang, Warburton, Pauline, Rowlings, Philip and Mollee, Peter (2017). ‘Real-world’ Australian experience of pomalidomide for relapsed and refractory myeloma. Leukemia and Lymphoma, 59 (6), 1514-1516. doi: 10.1080/10428194.2017.1387911 |
|
2017 Journal Article Bisphosphonate guidelines for treatment and prevention of myeloma bone diseaseLee, Oi Lin, Horvath, Noemi, Lee, Cindy, Joshua, Doug, Ho, Joy, Szer, Jeff, Quach, Hang, Spencer, Andrew, Harrison, Simon, Mollee, Peter, Roberts, Andrew W., Talaulikar, Dipti, Brown, Ross, Augustson, Bradley, Ling, Silvia, Jaksic, Wilfrid, Gibson, John, Kalff, Anna, Johnston, Anna, Kalro, Akash, Ward, Chris, Prince, H. Miles and Zannettino, Andrew (2017). Bisphosphonate guidelines for treatment and prevention of myeloma bone disease. Internal Medicine Journal, 47 (8), 938-951. doi: 10.1111/imj.13502 |
|
2017 Journal Article The duality of macrophage function in Chronic Lymphocytic LeukaemiaChen, Y. C. E., Mapp, S., Blumenthal, A., Burgess, M. L., Mazzieri, R., Mattarollo, S., Mollee, P., Gill, D. and Saunders, N. A. (2017). The duality of macrophage function in Chronic Lymphocytic Leukaemia. Biochimica et Biophysica Acta (BBA) Reviews on Cancer, 1868 (1), 176-182. doi: 10.1016/j.bbcan.2017.03.006 |
|
2017 Conference Publication First Australian registry of patients with wild type cardiac amyloidosis (ATTRwt): Queensland experienceBurrage, M., Korczyk, D. and Mollee, P. (2017). First Australian registry of patients with wild type cardiac amyloidosis (ATTRwt): Queensland experience. ESC Congress 2017, Barcelona, Spain, 26-30 August 2017. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/eurheartj/ehx502.1955 |
|
2017 Journal Article Monitoring of light chain myeloma - time for a changeMollee, Peter and Tate, Jill (2017). Monitoring of light chain myeloma - time for a change. British Journal of Haematology, 178 (2), 177-178. doi: 10.1111/bjh.14752 |
|
2017 Journal Article Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trialRickard, Claire M., Marsh, Nicole M., Webster, Joan, Gavin, Nicole C., Chan, Raymond J., McCarthy, Alexandra L., Mollee, Peter, Ullman, Amanda J., Kleidon, Tricia, Chopra, Vineet, Zhang, Li, McGrail, Matthew R., Larsen, Emily, Abu Choudhury, Md, Keogh, Samantha, Alexandrou, Evan, McMillan, David J., Mervin, Merehau Cindy, Paterson, David L., Cooke, Marie, Ray-Barruel, Gillian, Castillo, Maria Isabel, Hallahan, Andrew, Corley, Amanda and Playford, E. Geoffrey (2017). Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial. BMJ Open, 7 (6) e015291, e015291. doi: 10.1136/bmjopen-2016-015291 |
